Unknown

Dataset Information

0

Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.


ABSTRACT:

Background

Early detection of hepatocellular carcinoma (HCC) is important in order to improve patient prognosis and survival rate. Methylation sequencing combined with neural networks to identify cell-free DNA (cfDNA) carrying aberrant methylation offers an appealing and non-invasive approach for HCC detection. However, some limitations exist in traditional methylation detection technologies and models, which may impede their performance in the read-level detection of HCC.

Methods

We developed a low DNA damage and high-fidelity methylation detection method called No End-repair Enzymatic Methyl-seq (NEEM-seq). We further developed a read-level neural detection model called DeepTrace that can better identify HCC-derived sequencing reads through a pre-trained and fine-tuned neural network. After pre-training on 11 million reads from NEEM-seq, DeepTrace was fine-tuned using 1.2 million HCC-derived reads from tumor tissue DNA after noise reduction, and 2.7 million non-tumor reads from non-tumor cfDNA. We validated the model using data from 130 individuals with cfDNA whole-genome NEEM-seq at around 1.6X depth.

Results

NEEM-seq overcomes the drawbacks of traditional enzymatic methylation sequencing methods by avoiding the introduction of unmethylation errors in cfDNA. DeepTrace outperformed other models in identifying HCC-derived reads and detecting HCC individuals. Based on the whole-genome NEEM-seq data of cfDNA, our model showed high accuracy of 96.2%, sensitivity of 93.6%, and specificity of 98.5% in the validation cohort consisting of 62 HCC patients, 48 liver disease patients, and 20 healthy individuals. In the early stage of HCC (BCLC 0/A and TNM I), the sensitivity of DeepTrace was 89.6 and 89.5% respectively, outperforming Alpha Fetoprotein (AFP) which showed much lower sensitivity in both BCLC 0/A (50.5%) and TNM I (44.7%).

Conclusions

By combining high-fidelity methylation data from NEEM-seq with the DeepTrace model, our method has great potential for HCC early detection with high sensitivity and specificity, making it potentially suitable for clinical applications. DeepTrace: https://github.com/Bamrock/DeepTrace.

SUBMITTER: Deng Z 

PROVIDER: S-EPMC10631027 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.

Deng Zhenzhong Z   Ji Yongkun Y   Han Bing B   Tan Zhongming Z   Ren Yuqi Y   Gao Jinghan J   Chen Nan N   Ma Cong C   Zhang Yichi Y   Yao Yunhai Y   Lu Hong H   Huang Heqing H   Xu Midie M   Chen Lei L   Zheng Leizhen L   Gu Jianchun J   Xiong Deyi D   Zhao Jianxin J   Gu Jinyang J   Chen Zutao Z   Wang Ke K  

Genome medicine 20231108 1


<h4>Background</h4>Early detection of hepatocellular carcinoma (HCC) is important in order to improve patient prognosis and survival rate. Methylation sequencing combined with neural networks to identify cell-free DNA (cfDNA) carrying aberrant methylation offers an appealing and non-invasive approach for HCC detection. However, some limitations exist in traditional methylation detection technologies and models, which may impede their performance in the read-level detection of HCC.<h4>Methods</h4  ...[more]

Similar Datasets

| S-EPMC7073245 | biostudies-literature
| S-EPMC9814445 | biostudies-literature
| S-EPMC10905905 | biostudies-literature
| S-EPMC4769831 | biostudies-literature
| S-EPMC9811750 | biostudies-literature
| S-EPMC11873116 | biostudies-literature
| S-EPMC11702857 | biostudies-literature
| S-EPMC9866052 | biostudies-literature
| S-EPMC10293617 | biostudies-literature
| S-EPMC3461232 | biostudies-literature